SCHEMBL172869

SCHEMBL172869

C1CCC2CC3OC3CC2C1

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.44
TFPI2 P48307 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15978719 0.94 ALDH1A1 (0.39) ALDH1A1
SCHEMBL14232047 0.89 ALDH1A1 (0.35) ALDH1A1
SCHEMBL4197882 0.87 ALDH1A1 (0.40) ALDH1A1TFPI2
SCHEMBL13784893 0.80 TFPI2 (0.33) TFPI2
SCHEMBL14510049 0.80 TFPI2 (0.33) TFPI2
SCHEMBL658709 0.80 TFPI2 (0.33) TFPI2
SCHEMBL15813209 0.80 TFPI2 (0.33) TFPI2
SCHEMBL15980921 0.80 TFPI2 (0.33) TFPI2
SCHEMBL15685849 0.79 ALDH1A1 (0.44) ALDH1A1
SCHEMBL9924687 0.78 TFPI2 (0.32) TFPI2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10806683-B2 Encapsulated perfume compositions GIVAUDAN SA (CH) 2020-10-20 US disclosed
US-10722857-B2 Encapsulated perfume compositions GIVAUDAN S.A. (CH) 2020-07-28 US disclosed
US-10537868-B2 Microcapsules GIVAUDAN S.A. (CH) 2020-01-21 US disclosed
US-20180185808-A1 MICROCAPSULES GIVAUDAN SA (CH) 2018-07-05 US disclosed
US-20180177689-A1 IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS GIVAUDAN S.A. (CH) 2018-06-28 US disclosed
US-20180169603-A1 IMPROVEMENTS IN OR RELATING TO ENCAPSULATED PERFUME COMPOSITIONS GIVAUDAN S.A. (CH) 2018-06-21 US disclosed
US-8975349-B2 Cationically polymerizable resin composition and cured object obtained therefrom DAICEL CORPORATION (JP) 2015-03-10 US disclosed
US-20120077946-A1 CATIONICALLY POLYMERIZABLE RESIN COMPOSITION AND CURED OBJECT OBTAINED THEREFROM DAICEL CORPORATION (JP) 2012-03-29 US disclosed
EP-1521125-B1 Electrophotographic photoconductor, electrophotographic method, electrophotographic apparatus, process cartridge for electrophotographic apparatus and azo compound RICOH CO LTD (JP) 2012-03-07 EP disclosed
US-20120027342-A1 CATION-POLYMERIZABLE RESIN COMPOSITION AND CURED PRODUCT THEREOF DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 2012-02-02 US disclosed
US-20080234455-A1 Vinyl ether compounds and polymerizable compositions DAICEL CHEMICAL INDUSTRIES, LTD. 2008-09-25 US disclosed
US-20080039360-A1 Trisubstituted Furans Suitable For The Preparation Of Fragrance Compositions GIVAUDAN S.A. (CH) 2008-02-14 US disclosed
CN-1886390-A Musk odorant compound FIRMENICH & CIE (CH) 2006-12-27 CN disclosed
EP-1689728-A1 MUSK ODORANT COMPOUNDS FIRMENICH SA (CH) 2006-08-16 EP disclosed
WO-2005054220-A1 MUSK ODORANT COMPOUNDS FIRMENICH SA (CH) 2005-06-16 WO disclosed
EP-1000921-B1 Process for the preparation of beta-hydroxyaldehydes DEGUSSA (DE) 2002-04-03 EP disclosed
US-6180831-B1 REACTING 1,2-OXIRANES WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF COBALT TRANSITION METAL COMPOUND CATALYST, WHEREIN SAID COBALT TRANSITION METAL COMPOUND IS MODIFIED WITH PHOSPHORUS-OXYGEN LIGAND OR NITROGEN-OXYGEN LIGAND DEGUSSA-HULS AG (DE) 2001-01-30 US disclosed
EP-1000921-A1 Process for the preparation of beta-hydroxyaldehydes Degussa-Hüls Aktiengesellschaft (DE) 2000-05-17 EP disclosed
EP-0478850-B1 Process for the preparation of beta-hydroxy aldehydes SHELL INT RESEARCH (NL) 1994-09-14 EP disclosed
EP-0478850-A1 Process for the preparation of beta-hydroxy aldehydes SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1992-04-08 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080039360-A1 Trisubstituted Furans Suitable For The Preparation Of Fragrance Compositions TAS2R5, TAS2R1, DHPS ALDH1A1 163/4885TFPI2 1625/4885
US-20080234455-A1 Vinyl ether compounds and polymerizable compositions CBR1, ECH1, VDAC1 ALDH1A1 1778/4885TFPI2 4565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.